Use of an educational intervention to increase screening for antenatal depression in an obstetrics and gynecology practice.
Journal
Journal of the American Association of Nurse Practitioners
ISSN: 2327-6924
Titre abrégé: J Am Assoc Nurse Pract
Pays: United States
ID NLM: 101600770
Informations de publication
Date de publication:
23 Sep 2020
23 Sep 2020
Historique:
received:
14
04
2020
accepted:
24
06
2020
pubmed:
26
9
2020
medline:
25
11
2021
entrez:
25
9
2020
Statut:
epublish
Résumé
Depression affects approximately 12% of pregnant women and increases maternal and fetal risk during pregnancy and the postpartum period. The United States Preventative Services Task Force and the American College of Obstetricians and Gynecologists recommend that all prenatal care include depression screening. This study assessed the effectiveness of an educational intervention to increase screening for depression during prenatal care. The clinical site serves a socioeconomically and culturally high-risk population. Prior to the intervention, prenatal depression screening was not incorporated into prenatal care. Health records of patients presenting for prenatal care to an obstetrics and gynecology clinic were analyzed before an educational intervention on prenatal depression was delivered to providers at the practice site. Data for prenatal depression screening rates, treatment plans, and patient demographic information were extracted and compared to determine compliance with antenatal depression screening guidelines. The primary intervention of this initiative is the provision of education on the importance of and techniques for prenatal depression screening, diagnosis, and treatment. Prenatal depression screening increased from 0% to 27% of patients following the intervention. No significant correlation was found between factors of age, gestational age, gravidity, parity, or marital status. A total of 2.8% of screened patients scored positive for severe depression, 5.7% indicated moderate depression, and 51% indicated mild depression. Education and training improves provision of prenatal depression screening, but further work is needed to improve the accurate and timely identification of depression, as well as its appropriate treatment, referral, and follow-up.
Sections du résumé
BACKGROUND
BACKGROUND
Depression affects approximately 12% of pregnant women and increases maternal and fetal risk during pregnancy and the postpartum period. The United States Preventative Services Task Force and the American College of Obstetricians and Gynecologists recommend that all prenatal care include depression screening. This study assessed the effectiveness of an educational intervention to increase screening for depression during prenatal care.
LOCAL PROBLEM
OBJECTIVE
The clinical site serves a socioeconomically and culturally high-risk population. Prior to the intervention, prenatal depression screening was not incorporated into prenatal care.
METHODS
METHODS
Health records of patients presenting for prenatal care to an obstetrics and gynecology clinic were analyzed before an educational intervention on prenatal depression was delivered to providers at the practice site. Data for prenatal depression screening rates, treatment plans, and patient demographic information were extracted and compared to determine compliance with antenatal depression screening guidelines.
INTERVENTIONS
METHODS
The primary intervention of this initiative is the provision of education on the importance of and techniques for prenatal depression screening, diagnosis, and treatment.
RESULTS
RESULTS
Prenatal depression screening increased from 0% to 27% of patients following the intervention. No significant correlation was found between factors of age, gestational age, gravidity, parity, or marital status. A total of 2.8% of screened patients scored positive for severe depression, 5.7% indicated moderate depression, and 51% indicated mild depression.
CONCLUSIONS
CONCLUSIONS
Education and training improves provision of prenatal depression screening, but further work is needed to improve the accurate and timely identification of depression, as well as its appropriate treatment, referral, and follow-up.
Identifiants
pubmed: 32976252
pii: 01741002-202111000-00035
doi: 10.1097/JXX.0000000000000494
doi:
Types de publication
Journal Article
Langues
eng
Pagination
1093-1099Informations de copyright
Copyright © 2020 American Association of Nurse Practitioners.
Déclaration de conflit d'intérêts
Competing interests: The authors report no conflicts of interest.
Références
Accortt E. E., Cheadle A. C. D., Dunkel Schetter C. (2015). Antenatal depression and adverse birth outcomes: An updated systematic review. Maternal and Child Health Journal, 19, 1306–1337.
American College of Obstetricians and Gynecologists (2018). ACOG committee opinion No. 757: Screening for perinatal depression. Obstetrics and Gynecology, 132, e208–e212.
Arroll B., Goodyear-Smith F., Crengle S., Gunn J., Kerse N., Fishman T., Falloon K., Hatcher S. (2010). Validation of PHQ-2 and PHQ-9 to screen for major depression in the primary care population. Annals of Family Medicine, 8, 348–353.
Ashley J. M., Harper B. D., Arms-chavez C., Lobello S. G. (2016). Estimated prevalence of antenatal depression in the US population. Archives of Women's Mental Health, 19, 395–400.
Biaggi A., Conroy S., Pawlby S., Pariante C. M. (2016). Identifying the women at risk of antenatal anxiety and depression: A systematic review. Journal of Affective Disorders, 191, 62–77.
Cerimele J. M., Vanderlip E. R., Croieu C. A., Melville J. L., Russo J., Reed S. D., Katon W. (2014). Presenting symptoms of women with depression in an obstetrics and gynecology setting. Obstetrics and Gynecology, 122, 313–318.
Dagklis T., Papazisis G., Tsakiridis I., Chouliara F., Mamopoulos A., Rousso D. (2016) Prevalence of antenatal depression and associated factors among pregnant women hospitalized in a high-risk pregnancy unit in Greece. Social Psychiatry and Psychiatric Epidemiology, 51, 1025–1031.
Dean D. C., Planalp E. M., Wooten W. (2018). Association of antenatal maternal depression and anxiety symptoms with infant white matter microstructure. JAMA, 172, 973–981.
Evans M. G., Phillippi S., Gee R. E. (2015). Examining the screening practices of physicians for postpartum depression: Implications for improving health outcomes. Women's Health Issues, 25, 703–710.
Figueiredo B., Canário C., Field T. (2014). Breastfeeding is negatively affected by prenatal depression and reduces postpartum depression. Psychological Medicine, 44, 927–936.
Hahn-Hohlbrook J., Cornwell-Hinrichs T., Anaya I. (2018). Economic and health predictors of national postpartum depression prevalence: A systematic review, meta-analysis, and meta-regression of 291 studies from 56 countries. Frontiers in Psychiatry, 8, 248.
Kiely M., Gantz M. G., El-Khorazaty M. N., El-Mohandes A. A. E. (2013). Sequential screening for psychosocial and behavioural risk during pregnancy in a population of urban African Americans. Obstetrics and Gynecology, 120, 1395–1402.
Lebel C., Walton M., Letourneau N., Giesbrecht G. F., Kaplan B. J., Dewey D. (2016). Prepartum and postpartum maternal depressive symptoms are related to children's brain structure in preschool. Biological Psychiatry, 80, 85–87.
Leiferman J. A., Dauber S. E., Heisler K., Paulson J. F. (2008) Primary care physicians' beliefs and practices toward maternal depression. Journal of Womens Health, 17, 1143–1150.
Luke S., Salihu H. M., Alio A. P., Mbah A. K., Jeffers D., Berry E. L., Mishkit V. R. (2009). Risk factors for major antenatal depression among low-income African American women. Journal of Womens Health, 18, 1841–1846.
Marsay C., Manderson L., Subramaney U. (2018). Changes in mood after screening for antenatal anxiety and depression. Journal of Reproductive and Infant Psychology, 36, 347–362.
McAllister-Williams R. H., Baldwin D. S., Cantwell R., Easter A., Gilvarry E., Glover V., Green L., Gregoire A., Howard L. M., Jones I., Khalifeh H., Lingford-Hughes A., McDonald E., Micali N., Pariante C. M., Peters L., Roberts A., Smith N. C., Taylor D., Young A. H. (2017). British Association for Psychopharmacology consensus guidance on the use of psychotropic medication preconception, in pregnancy and postpartum 2017. Journal of Psychopharmacology, 31, 519–552.
Melo E. F. Jr., Cecatti J. G., Pacagnella R. C., Leite D. F., Vulcani D. E., Makuch M. Y. (2012). The prevalence of perinatal depression and its associated factors in two different settings in Brazil. Journal of Affective Disorders 136, 1204–1208.
Melville J. L., Reed S. D., Russo J., Croicu C. A., Ludman E., LaRocco-Cockburn A., Katon W. (2014). Improving care for depression in obstetrics and gynecology: A randomized controlled trial. Obstetrics and Gynecology, 123, 1237–1246.
Mestad R., Lane S. D., Hall M., Smith C. J., Carter D. B., Rubinstein R. A., Keefe R. H., Jones-Moore C. (2016). Prenatal depression: Screening and referral for women who are low income during antenatal care. Social Work in Public Health, 31, 557–564.
O'Mahen H. A., Henshaw E., Jones J. M., Flynn H. A. (2011). Stigma and depression during pregnancy. The Journal of Nervous and Mental Disease, 199, 257–262.
O'Connor E., Rossom R. C., Hennninger M., Groom H. C., Burda B. U. (2016). Primary care screening for and treatment of depression in pregnant and postpartum women: Evidence report and systematic review for the US Preventative Services Task Force. JAMA, 15, 388–406.
Rifkin-Graboi A., Bai J., Chen H., Hameed W. B., Sim L. W., Tint M. T., Leutscher-Broekman B., Chong Y. S., Gluckman P. D., Fortier M. V., Meaney M. J., Qiu A. (2013). Antenatal maternal depression associates with microstructure of right amygdala in neonates at birth. Biological Psychiatry, 74, 837–844.
Siu A. L., Bibbins-Domingo K., Grossman D. C., Baumann L. C., Davidson K. W., Ebell M., García F. A., Gillman M., Herzstein J., Kemper A. R., Krist A. H., Kurth A. E., Owens D. K., Phillips W. R., Phipps M. G., Pignone M. P.; US Preventive Services Task Force (USPSTF). (2016). Screening for depression in adults: US Preventive Services Task Force recommendation statement. JAMA, 315, 380–387.
Spitzer R. L., Williams J. B. W., Kroenke K. (n.d.). Patient health questionnaire. Pfizer. https://www.phqscreeners.com/sites/g/files/g10016261/f/201412/instructions.pdf .
Stark E. L., Shim J., Ross C. M., Miller E. S. (2019). The association between positive antenatal depression screening and breastfeeding initiation and continuation. American Journal of Perinatology, doi: 10.1055/s-0039-1695775
doi: 10.1055/s-0039-1695775
Taouk L. H., Matteson K. A., Stark L. M., Schulkin J. (2018). Antenatal depression screening and antidepressant prescription: Obstetrician-gynecologists' practices, opinions, and interpretation of evidence. Archives of Womens Mental Health, 21, 85–91.
Truijens S. E. M., Spek V., van Son M. J. M., Guid Oei S., Pop V. J. M. (2017). Different patterns of depressive symptoms during pregnancy. Archives of Womens Mental Health, 20, 539–546.
Tsakiridis I., Bousi V., Dagklis T., Sardeli C., Nikolopoulou V., Papazisis G. (2019). Epidemiology of antenatal depression among women with high-risk pregnancies due to obstetric complications: A scoping review. Archives of Gynecology and Obstetrics, 300, 849–859.
US Preventive Services Task Force (2019). Interventions to prevent perinatal depression: US Preventive Services Task Force recommendation statement. JAMA, 321, 580–587.
Venkatesh K. K., Nadel H., Blewett D., Freeman M. P., Kaimal A. J., Riley L. E. (2016). Implementation of universal screening for depression during pregnancy: Feasibility and impact on obstetric care. American Journal of Obstetrics and Gynecology, 215, 517.e1–8.
Wen D. J., Poh J. S., Ni S. N., Chong Y. S., Chen H., Kwek K., Shek L. P., Gluckman P. D., Fortier M. V., Meaney M. J., Qiu A. (2017). Influences of antenatal and postnatal maternal depression on amydgala volume and microstructure in young children. Translational Psychiatry, 7, e1103.
Wilkinson A., Anderson S., Wheeler S. B. (2017). Screening for and treating postpartum depression and psychosis: A cost-effectiveness analysis. Maternal and Child Health Journal, 21, 903–914.
Williams J., Ryan D., Thomas-Peter K., Walker J., Cadario B., Li D., Hanley G. (2014). Best practice guidelines for mental health disorders in the perinatal period. BC Reproductive Mental Health Program & Perinatal Services BC.
Wilusz M. J., Peters R. M., Cassidy-Bushrow A. E. (2013). Course of depressive symptoms across pregnancy in African American women. Journal of Midwifery & Womens Health, 59, 411–416.
World Health Organization. (2018). Depression. http://www.who.int/mediacentre/factsheets/fs369/en/ .
Zuithoff N., Vergouwe Y., King M., Nazareth I., van Wezep M. J., Moons K., Geerlings M. I. (2010). The Patient Health Questionnaire-9 for detection of major depressive disorder in primary care: Consequences of current thresholds in a cross-sectional study. BMC Family Practice, 11, 98.